NCT01466244View on ClinicalTrials.gov

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

November 11, 2011

Primary Completion Date

January 11, 2012

Study Completion Date

January 11, 2012

Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

cisplatin

GENETIC

gene expression analysis

GENETIC

microarray analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT01466244 - Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397 | Biotech Hunter | Biotech Hunter